Rep. Mariannette Miller-Meeks voted in favor of all 8 tracked bills classified as benefiting her top donor sectors—Pharmaceuticals & Biotech, Securities & Investment, and Electric Utilities—ranking #4 among House members on this metric. She voted yes on HR8454-117, the Medical Marijuana and Cannabidiol Research Expansion Act, classified as favoring the pharmaceutical sector, though she supported 3 of 4 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HJRES25-119 — Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule
FOLLOW THE TRAIL
◈ Ask the Analyst about Mariannette Miller-Meeks →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 26, 2026 · internal signal score 90/100.